查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1236867

糖尿病視網膜病變市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

到 2022 年，全球糖尿病視網膜病變市場將達到 76 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 108 億美元，顯示 2023 年至 2028 年之間的增長率 (CAGR) 為 6.1%。

糖尿病性視網膜病變 (DR) 是指糖尿病引起的視網膜血管損傷。 該疾病分為兩種類型：非增殖性 DR 和增殖性或進行性 DR。 它是由於血糖水平波動導致眼內感光組織異常生長引起的。 DR 的症狀包括視野中的暗斑或暗線、視力模糊或波動、色覺障礙和視力下降。 可通過熒光素血管造影、光學相干斷層掃描等檢查確診，治療包括眼內註射類固醇、激光治療、玻璃體切除術等。

世界上糖尿病患病率上升和老齡化人口增加是推動市場增長的主要因素。 此外，糖尿病致盲率上升也推動了市場增長。 公眾越來越意識到可用的治療方法和早期發現 DR 的好處。 結果是廣泛採用了技術先進的程序和設備，包括改進的眼科診斷和手術設備。 這些程序和設備能夠實現早期檢測、有效治療、更高的準確性和最小的患者不適。 其他因素，如不斷上漲的醫療保健成本、實施有利的政府政策以向大眾提供先進的醫療保健服務，以及廣泛的研發活動，預計將進一步推動市場。

主要市場細分

  • IMARC Group 分析了全球糖尿病視網膜病變市場報告每個子部分的主要趨勢，並預測了 2023 年至 2028 年在全球、區域和國家層面的情況。 該報告按類型、治療類型和最終用戶細分市場。

本報告中回答的關鍵問題

  • 全球糖尿病視網膜病變市場迄今為止進展如何，未來幾年將如何發展？
  • 主要的區域市場是什麼？
  • COVID-19 對全球糖尿病視網膜病變市場有何影響？
  • 按類型劃分的市場細分情況如何？
  • 按治療類型劃分的市場細分情況如何？
  • 最終用戶的市場細分情況如何？
  • 行業價值鏈中有哪些不同階段？
  • 該行業的主要驅動因素和挑戰是什麼？
  • 全球糖尿病視網膜病變市場的結構和主要參與者是什麼？
  • 您所在行業的競爭力如何？

內容

第一章前言

第二章範圍與研究方法

  • 調查目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章糖尿病視網膜病變的全球市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 增生性糖尿病視網膜病變
    • 市場趨勢
    • 市場預測
  • 非增殖性視網膜病變
    • 關於市場趨勢
    • 市場預測

第 7 章按治療類型劃分的市場細分

  • 抗 VEGF 藥物
    • 關於市場趨勢
    • 市場預測
  • 類固醇植入物
    • 關於市場趨勢
    • 市場預測
  • 激光手術
    • 關於市場趨勢
    • 市場預測
  • 玻璃體手術
    • 關於市場趨勢
    • 市場預測

第 8 章最終用戶市場細分

  • 用於醫院和藥房
    • 市場趨勢
    • 市場預測
  • 眼科診所
    • 市場趨勢
    • 市場預測
  • 門診手術中心 (ASC)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 關於市場趨勢
      • 市場預測
    • 日本
      • 關於市場趨勢
      • 市場預測
    • 印度
      • 關於市場趨勢
      • 市場預測
    • 韓國
      • 關於市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印度尼西亞
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 關於市場趨勢
      • 市場預測
    • 西班牙
      • 關於市場趨勢
      • 市場預測
    • 俄羅斯
      • 關於市場趨勢
      • 市場預測
    • 其他
      • 關於市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 關於市場趨勢
      • 市場預測
    • 墨西哥
      • 關於市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場預測

第 10 章 SWOT 分析

  • 概覽
  • 力量
  • 弱點
  • 機會
  • 威脅

第11章價值鏈分析

第12章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Alimera Sciences
    • Allergan Plc
    • Ampio Pharmaceuticals
    • Bayer Healthcare
    • BCN Peptides
    • Genentech
    • Kowa Group
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Sirnaomics Inc.
Product Code: SR1523A132_Report

The global diabetic retinopathy market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of two kinds, namely non-proliferative DR and proliferative or advanced DR. It is caused by fluctuations in the blood glucose levels resulting in an abnormal growth in the light-sensitive tissues present in the eye. The symptoms of DR include the visibility of dark spots or floating strings in the vision field, blurred or fluctuating vision, impaired color vision or loss of vision. It can be diagnosed through tests, such as fluorescein angiography and optical coherence tomography, and the treatment involves the use of intraocular steroid injection, laser treatment and vitrectomy.

The increasing prevalence of diabetes, along with the growing geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the rising incidence of blindness caused by DR is also providing a boost to the market growth. There is an increasing awareness among the masses regarding the available treatment alternatives and the benefits of early detection of DR. This has resulted in the widespread adoption of technologically advanced procedures and equipment, such as the improved ophthalmic diagnostic and surgical instruments. These procedures and equipment enable early detection and efficient treatment of the ailment with higher precision and minimal discomfort to the patient. Other factors, including the increasing healthcare expenditures, the implementation of favorable government policies to make advanced healthcare services available to the masses and extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end-user.

Breakup by Type:

  • Proliferative Diabetic Retinopathy
  • Non-proliferative Retinopathy

Breakup by Treatment Type:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

Breakup by End-User:

  • Hospitals and Pharmacies
  • Eye Clinics
  • Ambulatory Surgical Centres (ASCs)
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global diabetic retinopathy market?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global diabetic retinopathy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proliferative Diabetic Retinopathy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proliferative Retinopathy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Anti VEGF Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Steroid Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitrectomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eye Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centres (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Alimera Sciences
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Allergan Plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Ampio Pharmaceuticals
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bayer Healthcare
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 BCN Peptides
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Genentech
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Kowa Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Regeneron Pharmaceuticals Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sirnaomics Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2022
  • Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2022
  • Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2022
  • Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
  • Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
  • Figure 78: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
  • Table 7: Global: Diabetic Retinopathy Market: Key Players